rivastigmine has been researched along with Age-Related Memory Disorders in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.45) | 18.2507 |
| 2000's | 12 (41.38) | 29.6817 |
| 2010's | 13 (44.83) | 24.3611 |
| 2020's | 3 (10.34) | 2.80 |
| Authors | Studies |
|---|---|
| Ang, W; Deng, Y; Li, Y; Liu, Q; Luo, Y; Qiang, X; Sang, Z; Shi, Y; Tan, Z; Yuan, W | 1 |
| Akbarzadeh, T; Asatouri, R; Karimpour-Razkenari, E; Khanavi, M; Mahdavi, M; Moghadam, FH; Najafi, Z; Saeedi, M; Sharifzadeh, M; Vafadarnejad, F | 1 |
| Karami, E; Mehri, K; Nassireslami, E; Oskuye, ZZ; Parvizi, MR | 1 |
| Arumugam, K; Bojja, SL; Kumar, N; Rao, CM; Rompicherla, SKL | 1 |
| Brody, DL | 1 |
| Bellman, S | 1 |
| Haque-Hussain, S; Khoo, ABS | 1 |
| Borah, A; Dutta, A; Gothwal, A; Gupta, U; Jain, SK; Singh, H | 1 |
| Anturlikar, SD; Kavya, KJ; Patki, PS; Rafiq, M; Thippeswamy, AH; Viswantha, GL | 1 |
| Fukunaga, K; Moriguchi, S; Narahashi, T; Sakagami, H; Sasaki, Y; Tagashira, H; Yeh, JZ | 1 |
| Dong, S; Gao, X; He, D; Wang, D; Zhang, Y; Zhou, H | 1 |
| Akaishi, T | 1 |
| Blokland, A; de Sousa Fernandes Perna, EB; Heckman, P; Kuypers, KP; Prickaerts, J; Ramaekers, JG; Sambeth, A; Theunissen, EL; Toennes, SW | 1 |
| Filarowska, J; Gawel, K; Gibula-Bruzda, E; Jenda, M; Kotlinska, JH; Labuz, K; Marszalek-Grabska, M; Silberring, J | 1 |
| Hisatsune, T; Matsuda, T | 1 |
| Ashtari, F; Janghorbani, M; Shaygannejad, V; Zakizade, N; Zanjani, HA | 1 |
| Barichello, T; Comim, CM; Dal-Pizzol, F; Pereira, JG; Petronilho, F; Quevedo, J; Steckert, A | 1 |
| Guo, D; Hao, Z; He, D; Wu, B; Zhou, H | 1 |
| Adler, G; Brassen, S | 1 |
| Abdullah, L; Crowell, TA; Mullan, M; Paramadevan, J | 1 |
| Bentaleb, LA; Chouinard, S; Godbout, R; Guillem, F; Lalonde, P; Melun, P; Poulin, J; Stip, E | 1 |
| Appels, BA; Beijnen, JH; De Boer, A; Frankfort, SV; Koks, CH; Tulner, LR; Van Campen, JP | 1 |
| Chilovi, BV; Costardi, D; Franzoni, S; Padovani, A; Rozzini, L; Trabucchi, M | 1 |
| Hauser, WA; Noble, JM | 1 |
| Anderson, KE; Bell, K; Brickman, AM; Flynn, J; Marder, KS; Moeller, JR; Sackeim, H; Scarmeas, N; Stern, Y; Van Heertum, R | 1 |
| Avila, R; Bottino, CM; Carvalho, IA; Miotto, EC | 1 |
| Demura, N; Fukaya, H; Iimura, A; Ohara, T; Seno, N; Tanaka, K | 1 |
| Bejar, C; Wang, RH; Weinstock, M | 1 |
| Baik, J; Han, IW; Koo, MS; Kwak, YT | 1 |
4 review(s) available for rivastigmine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Pharmacological treatment for memory disorder in multiple sclerosis.
Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2017 |
Pharmacological treatment for memory disorder in multiple sclerosis.
Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2013 |
[Memory-enhancing drugs].
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cyclic AMP Response Element-Binding Protein; Donepezil; Drug Discovery; Extracellular Signal-Regulated MAP Kinases; Galantamine; Hippocampus; Humans; Indans; Long-Term Potentiation; Memantine; Memory; Memory Disorders; Molecular Targeted Therapy; Nootropic Agents; Phenylcarbamates; Piperidines; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Synaptic Transmission | 2014 |
Pharmacologic treatment for memory disorder in multiple sclerosis.
Topics: Adult; Donepezil; Ginkgo biloba; Humans; Indans; Memantine; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine | 2011 |
7 trial(s) available for rivastigmine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.
Topics: Acetylcholine; Adult; Attention; Cannabinoids; Cannabis; Cognition; Cross-Over Studies; Double-Blind Method; Female; Glutamic Acid; Humans; Imidazoles; Male; Marijuana Smoking; Memory; Memory Disorders; Memory, Short-Term; Phenylcarbamates; Piperazines; Prospective Studies; Rivastigmine; Sulfones; Triazines; Vardenafil Dihydrochloride; Verbal Learning; Young Adult | 2015 |
Effects of rivastigmine on memory and cognition in multiple sclerosis.
Topics: Adolescent; Adult; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Humans; Memory Disorders; Middle Aged; Multiple Sclerosis; Neuroprotective Agents; Phenylcarbamates; Placebos; Psychological Tests; Rivastigmine | 2008 |
Short-term effects of acetylcholinesterase inhibitor treatment on EEG and memory performance in Alzheimer patients: an open, controlled trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Electroencephalography; Female; Humans; Indans; Male; Memory; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Theta Rhythm; Time Factors; Treatment Outcome | 2003 |
Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Female; Humans; Indans; Male; Memory Disorders; Mental Recall; Mental Status Schedule; Neuropsychological Tests; Phenylcarbamates; Piperidines; Retention, Psychology; Rivastigmine; Verbal Learning | 2006 |
Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.
Topics: Adult; Antipsychotic Agents; Cholinesterase Inhibitors; Cross-Over Studies; Electroencephalography; Evoked Potentials; Female; Humans; Male; Memory Disorders; Phenylcarbamates; Psychiatric Status Rating Scales; Rivastigmine; Schizophrenia; Schizophrenic Psychology | 2006 |
Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
Topics: Activities of Daily Living; Aged; Cholinesterase Inhibitors; Cognition Disorders; Combined Modality Therapy; Computer-Assisted Instruction; Donepezil; Female; Galantamine; Humans; Indans; Intelligence; Longitudinal Studies; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Nootropic Agents; Orientation; Phenylcarbamates; Piperidines; Problem Solving; Retrospective Studies; Rivastigmine; Software; Treatment Outcome | 2007 |
Neuropsychological rehabilitation in mild and moderate Alzheimer's disease patients.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cognitive Behavioral Therapy; Female; Humans; Male; Memory Disorders; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Treatment Outcome; Verbal Learning | 2007 |
18 other study(ies) available for rivastigmine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amines; Amyloid beta-Peptides; Animals; Antioxidants; Apigenin; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Humans; Hydrogen Peroxide; Memory Disorders; Mice; Models, Molecular; Molecular Structure; PC12 Cells; Peptide Fragments; Rats; Scopolamine; Structure-Activity Relationship | 2015 |
Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Cell Death; Cell Line; Cell Line, Tumor; Cholinesterase Inhibitors; Humans; Kinetics; Male; Memory Disorders; Molecular Docking Simulation; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Structure-Activity Relationship; Tacrine; Triazoles | 2017 |
Rivastigmine ameliorates botulinum-induced hippocampal damage and spatial memory impairment in male rats.
Topics: Acetylcholinesterase; Animals; Botulinum Toxins, Type A; Clostridium botulinum; Hippocampus; Male; Maze Learning; Memory Disorders; Rats; Rats, Wistar; Rivastigmine; Spatial Memory | 2023 |
Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer's disease.
Topics: Administration, Intranasal; Alzheimer Disease; Animals; Area Under Curve; Biological Availability; Cholinesterase Inhibitors; Colchicine; Disease Models, Animal; Liposomes; Male; Maze Learning; Memory Disorders; Models, Biological; Nanoparticles; Rats; Rats, Wistar; Rivastigmine; Scopolamine | 2021 |
Taking a Bite of the Elephant: A Well-Executed Clinical Trial Answers a Key Question About Rivastigmine Treatment for Memory Impairment after TBI.
Topics: Brain Injuries, Traumatic; Cholinesterase Inhibitors; Humans; Memory Disorders; Rivastigmine | 2021 |
A differential diagnosis for annular lesions: contact dermatitis to transdermal rivastigmine patches.
Topics: Aged; Dermatitis, Contact; Diagnosis, Differential; Humans; Male; Memory Disorders; Neuroprotective Agents; Rivastigmine; Transdermal Patch | 2018 |
Behavioral and Biochemical Implications of Dendrimeric Rivastigmine in Memory-Deficit and Alzheimer's Induced Rodents.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Brain; Bridged-Ring Compounds; Disease Models, Animal; Drug Combinations; Maze Learning; Memory Disorders; Mice; Motor Skills; Organometallic Compounds; Polysaccharides; Rats; Rats, Wistar; Rivastigmine; Rotarod Performance Test; Scopolamine; Spatial Memory | 2019 |
Evaluation of Bacopa monniera for its synergistic activity with rivastigmine in reversing aluminum-induced memory loss and learning deficit in rats.
Topics: Aluminum; Animals; Bacopa; Drug Synergism; Drug Therapy, Combination; Humans; Learning; Male; Memory Disorders; Phenylcarbamates; Plant Extracts; Rats; Rats, Wistar; Rivastigmine | 2013 |
CaMKII activity is essential for improvement of memory-related behaviors by chronic rivastigmine treatment.
Topics: Alzheimer Disease; Animals; Animals, Outbred Strains; CA1 Region, Hippocampal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Cholinesterase Inhibitors; Denervation; Disease Models, Animal; Long-Term Potentiation; Male; Memory; Memory Disorders; Mice; Olfactory Bulb; Phenylcarbamates; Rivastigmine | 2014 |
Cholinesterase inhibitors, donepezil and rivastigmine, attenuate spatial memory and cognitive flexibility impairment induced by acute ethanol in the Barnes maze task in rats.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Dose-Response Relationship, Drug; Ethanol; Indans; Male; Maze Learning; Memory Disorders; Motor Activity; Nootropic Agents; Piperidines; Rats, Wistar; Reaction Time; Rivastigmine; Rotarod Performance Test; Spatial Memory; Time Factors | 2016 |
Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer's Disease Model Mice Fed a High-Fat Diet.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Body Weight; Cells, Cultured; Cholinesterase Inhibitors; Conditioning, Psychological; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gliosis; Humans; Insulin; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurogenesis; Neurons; Presenilin-1; Rivastigmine | 2017 |
Rivastigmine reverses habituation memory impairment observed in sepsis survivor rats.
Topics: Animals; Behavior, Animal; Cecum; Habituation, Psychophysiologic; Male; Memory Disorders; Neuroprotective Agents; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine; Sepsis | 2009 |
Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric setting.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Ambulatory Care; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Female; Humans; Male; Memory Disorders; Middle Aged; Phenylcarbamates; Retrospective Studies; Rivastigmine; Treatment Outcome | 2006 |
Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Topics: Brain Injuries; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Humans; Memory Disorders; Neuroprotective Agents; Neuropsychological Tests; Phenylcarbamates; Research Design; Rivastigmine; Treatment Outcome | 2007 |
Impairment of nonverbal recognition in Alzheimer disease: a PET O-15 study.
Topics: Adaptation, Physiological; Aged; Alzheimer Disease; Brain Mapping; Cerebrovascular Circulation; Cholinesterase Inhibitors; Donepezil; Female; Frontal Lobe; Hippocampus; Humans; Indans; Magnetic Resonance Imaging; Male; Memory Disorders; Middle Aged; Neuropsychological Tests; Nootropic Agents; Oxygen Radioisotopes; Pattern Recognition, Visual; Phenylcarbamates; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Rivastigmine; Temporal Lobe | 2007 |
SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Brain Chemistry; Carbamates; Choline O-Acetyltransferase; Cholinergic Antagonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Memory Disorders; Microdialysis; Parasympathetic Nervous System; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine; Scopolamine; Space Perception | 1997 |
Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats.
Topics: Animals; Brain; Carbamates; Cholinesterase Inhibitors; Cholinesterases; Female; Male; Memory; Memory Disorders; Muscarinic Antagonists; Muscle, Skeletal; Myocardium; Orchiectomy; Ovariectomy; Phenylcarbamates; Physostigmine; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Sex Factors | 2000 |
Relation between cholinesterase inhibitor and Pisa syndrome.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dystonia; Female; Humans; Indans; Memory Disorders; Middle Aged; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Posture; Psychomotor Agitation; Risperidone; Rivastigmine; Syndrome | 2000 |